Agenda

7:30 – 8:00 Registration / Breakfast
8:00 – 8:15 Introduction
8:15 – 8:45 Unraveling Heterogeneity in Psoriatic Arthritis
Speaker: Dr. Oliver FitzGerald
Newman Clinical Research Professor, St Vincent’s University Hospital and Conway Institute for Biomolecular Research, University College Dublin
8:45 – 9:15 Potential Clinical Applications of Genetic Variants in PsA – Lessons Learned and Future Directions
Speaker: Dr. Proton Rahman
Associate Dean, Clinical Research, Professor of Medicine (Rheumatology
Memorial University
9:15 – 9:45 Genetics and Genomics of Psoriasis and Psoriatic Arthritis: Big Data at Work
Speaker: Dr. James T Elder
Kirk D. Wuepper Professor of Molecular Genetic Dermatology, Department of Dermatology, University of Michigan
9:45 – 10:15 Proteomics in Psoriatic Disease – Achievements and Opportunities
Speaker: Dr. Stephen Pennington
Professor of Proteomics, University College Dublin
10:15-10:30 BREAK
10:30 – 11:00 Microbiome in PsA: From Pathogenesis to Pharmacomicrobiomics
Speaker: Dr. Jose Scher
Assistant Professor of Medicine, Director Microbiome Center for Rheumatology and Autoimmunity, New York University School of Medicine
11:00 – 11:30 Integrative Computational Biology and AI in Precision Medicine
Speaker: Dr. Igor Jurisica
Professor, Departments of Computer Science and Medical Biophysics, University of Toronto, Senior Scientist, Krembil Research Institute
11:30 – 12:00 Comorbidities
Speaker: Dr. Wolf-Henning Boehncke
Professor of Medicine, Division of Dermatology and Venerology,
University of Geneva
12:00 – 1:00 LUNCH
1:00 – 1:30 Review of Current Therapies
Speaker: Dr. Philip Mease
Director, Rheumatology Research, Swedish-Providence-St. Joseph Health Network and Clinical Professor, University of Washington School of Medicine, Seattle, Washington
1:30 – 2:00 Evolving Treatment – Toward Precision Medicine
Speaker: Dr. Christopher Ritchlin
Professor of Medicine, Division of Rheumatology, University of Rochester
2:00 – 2:30 Road Map for the Future
Speaker: Dr. Philip Helliwell
Leeds Institute of Molecular Medicine, University of Leeds
2:30 – 3:00 Panel Discussion
3:00 – 3:15 Closing Remarks